Tirzepatide monthly cost in the UK: the honest picture

What official pricing data tells us about the current monthly cost of tirzepatide

NICE's appraisal of tirzepatide (TA1026, published December 2024 and updated September 2025) confirmed tirzepatide's clinical effectiveness for weight management in adults, a finding grounded in the SURMOUNT-1 trial, where participants lost an average of around 20–21% of their body weight at the highest dose over 72 weeks. That evidence base matters here because it is partly what drove demand, and demand is what made pricing a live question.

On the supply side, Eli Lilly adjusted Mounjaro's UK list price from 1 September 2025, with the highest-dose pen rising from roughly £122 to around £330 at list. Private providers price above that floor to cover dispensing, prescribing, consultation and logistics. As widely reported, typical private monthly prices since that adjustment have run from roughly £149 at the starter dose to around £375 at higher doses, varying by provider, and our Mounjaro price guide sets out how those figures are structured across the range. These are the only £ figures worth quoting, and even then they are a starting point rather than a settled market rate.

The figure that matters most for any individual patient is not the headline number but the dose at which their prescriber stabilises them. Treatment begins at 2.5 mg (a dose whose job is to let your system adjust, not to deliver the full therapeutic effect) and titrates upward, typically in four-week steps, based on how you respond and what the prescriber judges appropriate. If you want to understand what you might expect to pay once you reach the mid-range, our page on tirzepatide 10 mg cost explains what that particular dose typically comes to. For a breakdown of how costs shift across the dose schedule, the tirzepatide cost guide covers the full picture.

What headline monthly prices often leave out

A number posted on a landing page rarely tells the whole story. Some providers charge separately for the initial consultation, the prescription, or delivery. Others bundle everything but make ongoing clinical review conditional on purchasing a subscription. When those extras surface at checkout (or when a repeat order requires a separate fee to speak to a prescriber) the headline figure becomes unreliable as a basis for comparison.

The clinical review is not a formality. Before any repeat of a prescription-only medicine, a prescriber should be checking whether the treatment is still appropriate, whether the dose should change, and whether anything in your health picture has shifted. That process has a cost regardless of whether it is itemised. A price that appears unusually low often reflects one of two things: a service where that review is thin, or (in the cases the MHRA has acted against) a supply chain that is not legitimate at all.

There are also costs that sit outside the pharmacy relationship entirely: whether you are eating enough protein alongside treatment, whether you have someone to speak to if a side effect feels worrying on a Saturday afternoon. Those things are worth weighing alongside the monthly figure. Our frequently asked questions cover some of the practical realities patients ask about most.

Where nume sits on price, and why

One transparent monthly price at nume covers the consultation, the prescription, the medicine, tracked next-working-day delivery and 7-day aftercare. There is no subscription, no auto-renewal and no separate delivery charge. Repeat orders are not processed automatically; a prescriber re-reviews each one before it is approved and dispatched.

We are not the cheapest option in the market. That is a deliberate position, not an oversight. The question of what a legitimate, clinically supervised, genuine-supply-chain service actually costs is answered by what it includes, and we would rather that be transparent upfront than discovered after an order arrives.

If you are ordering around a particular date (payday, a Monday before a busy week, the gap before a bank holiday) the 12pm cut-off for same-day dispatch on Monday to Friday is worth keeping in mind. Orders placed and approved before that point are with DPD the same afternoon and arrive the next working day. If you are thinking ahead to what treatment costs on an ongoing basis, our guide to the Mounjaro monthly cost breaks down what patients typically pay at each stage of treatment. Current treatment pricing is available on our treatment page; the per-dose cost context for specific strengths is covered in detail for 5 mg and 15 mg separately.

Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has been explicit: these are prescription-only medicines, not consumer goods. In October 2023 the agency warned publicly about counterfeit weight-loss pens being sold online and through social media; enforcement through 2025 included the seizure of approximately 20 million doses of illegally traded medicines (around £45 million in street value) and the raid of a Northampton site producing fake tirzepatide pens. Some counterfeits have contained insulin. None of this is hypothetical.

The red flags are consistent: sellers offering tirzepatide without a prescription, prices that sit well below the market floor, discount codes from unfamiliar sources. For a medicine that requires clinical supervision to be safe and effective, the cheapest listing answers the wrong question. You can verify any online pharmacy on the GPhC pharmacy register; nume's GPhC premises registration is 9012878, verifiable directly. Suspected illegal sellers can be reported through the MHRA Yellow Card scheme.

The right metric is whether the service dispensing your treatment is registered, the prescriber reviewing your case is qualified, and the supply chain behind the pen in your fridge is authorised. Our about page explains how nume is structured to meet each of those standards. To find out whether tirzepatide is clinically suitable for you, the starting point is a free consultation with one of our prescribers.